Literature DB >> 20960300

Ion channels as antivirus targets.

Xin Liang1, Zhi-Yuan Li.   

Abstract

Ion channels are membrane proteins that are found in a number of viruses and which are of crucial physiological importance in the viral life cycle. They have one common feature in that their action mode involves a change of electrochemical or proton gradient across the bilayer lipid membrane which modulates viral or cellular activity. We will discuss a group of viral channel proteins that belong to the viroproin family, and which participate in a number of viral functions including promoting the release of viral particles from cells. Blocking these channel-forming proteins may be "lethal", which can be a suitable and potential therapeutic strategy. In this review we discuss seven ion channels of viruses which can lead serious infections in human beings: M2 of influenza A, NB and BM2 of influenza B, CM2 of influenza C, Vpu of HIV-1, p7 of HCV and 2B of picornaviruses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960300      PMCID: PMC8227895          DOI: 10.1007/s12250-010-3136-y

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  95 in total

1.  Membrane interactions and alignment of structures within the HIV-1 Vpu cytoplasmic domain: effect of phosphorylation of serines 52 and 56.

Authors:  P Henklein; R Kinder; U Schubert; B Bechinger
Journal:  FEBS Lett       Date:  2000-10-06       Impact factor: 4.124

2.  Exploring models of the influenza A M2 channel: MD simulations in a phospholipid bilayer.

Authors:  L R Forrest; A Kukol; I T Arkin; D P Tieleman; M S Sansom
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

3.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

4.  Biological significance of a human enterovirus B-specific RNA element in the 3' nontranslated region.

Authors:  Ingrid Merkle; Mark J M van Ooij; Frank J M van Kuppeveld; Dirk H R F Glaudemans; Jochem M D Galama; Andreas Henke; Roland Zell; Willem J G Melchers
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Two models of the influenza A M2 channel domain: verification by comparison.

Authors:  L R Forrest; W F DeGrado; G R Dieckmann; M S Sansom
Journal:  Fold Des       Date:  1998

6.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

7.  The interplay of functional tuning, drug resistance, and thermodynamic stability in the evolution of the M2 proton channel from the influenza A virus.

Authors:  Amanda L Stouffer; Chunlong Ma; Lidia Cristian; Yuki Ohigashi; Robert A Lamb; James D Lear; Lawrence H Pinto; William F DeGrado
Journal:  Structure       Date:  2008-07       Impact factor: 5.006

8.  Proton transport behavior through the influenza A M2 channel: insights from molecular simulation.

Authors:  Hanning Chen; Yujie Wu; Gregory A Voth
Journal:  Biophys J       Date:  2007-08-10       Impact factor: 4.033

9.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

10.  Vpu matchmakers as a therapeutic strategy for HIV infection.

Authors:  Mauricio Montal
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more
  6 in total

1.  Emodin inhibits current through SARS-associated coronavirus 3a protein.

Authors:  Silvia Schwarz; Kai Wang; Wenjing Yu; Bing Sun; Wolfgang Schwarz
Journal:  Antiviral Res       Date:  2011-02-26       Impact factor: 5.970

2.  Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus.

Authors:  Silvia Schwarz; Daniel Sauter; Kai Wang; Ronghua Zhang; Bing Sun; Anastasia Karioti; Anna Rita Bilia; Thomas Efferth; Wolfgang Schwarz
Journal:  Planta Med       Date:  2014-01-23       Impact factor: 3.352

Review 3.  The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection.

Authors:  Mohammad Reza Kalhori; Fatemeh Saadatpour; Ehsan Arefian; Masoud Soleimani; Mohammad Hosien Farzaei; Ina Yosifova Aneva; Javier Echeverría
Journal:  Front Pharmacol       Date:  2021-02-23       Impact factor: 5.810

Review 4.  Topology and biological function of enterovirus non-structural protein 2B as a member of the viroporin family.

Authors:  Da Ao; Shi-Qi Sun; Hui-Chen Guo
Journal:  Vet Res       Date:  2014-08-28       Impact factor: 3.683

5.  PSIONplus: Accurate Sequence-Based Predictor of Ion Channels and Their Types.

Authors:  Jianzhao Gao; Wei Cui; Yajun Sheng; Jishou Ruan; Lukasz Kurgan
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

Review 6.  The elusive function of the hepatitis C virus p7 protein.

Authors:  Ali M Atoom; Nathan G A Taylor; Rodney S Russell
Journal:  Virology       Date:  2014-07-04       Impact factor: 3.616

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.